IL-6 Regulation of Substrate Metabolism and Influence of Obesity
NCT03967691
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
22
Enrollment
OTHER
Sponsor class
Conditions
Obesity
Healthy
Interventions
DRUG:
Tocilizumab infusion
DRUG:
Saline 0.9%
Sponsor
Rigshospitalet, Denmark